Factor X

Company Overview

Snapshot

Founded in December 2025 by Inbal Gat and Shira Orr, Factor X operates with 1–10 employees. The company secured Seed funding in July 2026, marking a significant early milestone in its development.

Business overview

Factor X is developing a cosmetic-grade topical delivery platform designed to deliver RNA and other active payloads across the skin barrier to specific skin layers. This technology aims to provide more precise, stable, and efficient formulations for skincare and cosmetic partners, addressing applications such as skin longevity, UV-damaged skin, hair color, and hair regrowth. The company operates within the Health Tech & Life Sciences sector, specifically focusing on Pharma & Medical Biotechnology and Cosmetic Materials, serving enterprise and professional services, including SMBs and larger enterprises.

Strategic signal

In July 2026, Factor X closed its pre-Seed funding round, a critical early validation for its innovative topical RNA delivery platform. This funding signals investor confidence in the company's potential to disrupt the skincare and cosmetic markets by offering advanced solutions for precision skin longevity and cosmetic performance, moving its R&D efforts forward.

Company Intelligence Q&A

What is Factor X's core technology?

Factor X is developing a cosmetic-grade topical delivery platform that carries RNA and other active payloads across the skin barrier to specific skin layers, aiming for precise, stable, and efficient formulations.

When was Factor X founded?

Factor X was founded in December 2025.

Who are the founders of Factor X?

The co-founders of Factor X are Inbal Gat, who serves as CEO, and Shira Orr.

Which markets does Factor X target?

Factor X targets skincare and cosmetic partners seeking advanced formulations for skin longevity, UV-damaged skin, hair color, and hair regrowth applications, serving enterprise and professional services, including SMBs and larger enterprises.